Prospective analysis shows cumulative metabolic fat score correlates with increased stroke risk in adults, suggesting predictive potential.
• Each 1-SD rise in cumulative METS-VF increased stroke risk by 29% (HR=1.29, 95% CI: 1.08–1.54, P<0.01). • A METS-VF threshold of 6.84 optimally stratified stroke risk (Log-rank P<0.001). • KM curves showed a 3.4-fold higher 60-month stroke rate in Q4 (17.0%) vs. Q1 (5.0%), diverging from 12 months. • Cumulative METS-VF best predicted stroke risk (AUC=0.606) vs. BMI, ABSI, METS-IR. Each 1-SD rise in cumulative METS-VF increased stroke risk by 29% (HR=1.29, 95% CI: 1.08–1.54, P<0.01). A METS-VF threshold of 6.84 optimally stratified stroke risk (Log-rank P<0.001). KM curves showed a 3.4-fold higher 60-month stroke rate in Q4 (17.0%) vs. Q1 (5.0%), diverging from 12 months. Cumulative METS-VF best predicted stroke risk (AUC=0.606) vs. BMI, ABSI, METS-IR. Stroke is a leading cause of death and disability worldwide, influenced by complex metabolic and lifestyle factors. The Metabolic Visceral Fat Index (METS-VF) has recently gained attention as a key measure of metabolic burden. This study examines the relationship between cumulative METS-VF and stroke risk. This study used the China Health and Retirement Longitudinal Study (CHARLS) database and a multivariate Cox regression model to explore the relationship between cumulative METS-VF and stroke risk. Kaplan-Meier (KM) curves, restricted cubic splines (RCS), and receiver operating characteristic (ROC) analysis were utilized to assess dose-response relationships and predictive performance. The research also examined the effects of cumulative exposure duration and burden on stroke risk, with subgroup and sensitivity analyses to confirm robustness. In a study of 4,069 participants, 347 strokes (8.5%) occurred. Multivariate Cox regression revealed that the highest exposure group (Q4) had more than double the stroke risk of the lowest group (Q1), with a hazard ratio (HR) of 2.12. A one standard deviation increase in cumulative METS-VF raised stroke risk by 29%. The optimal threshold was 6.84, above which stroke risk significantly increased. KM survival analysis supported this link, and ROC analysis indicated that cumulative METS-VF was a predictor of stroke risk, with an area under the curve (AUC) of 0.606. Subgroup and sensitivity analyses validated these findings. This study identifies cumulative METS-VF as an independent stroke risk factor, with both its duration and cumulative burden affecting risk, providing new insights for prevention and intervention.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: